Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002655131 | SCV003526047 | uncertain significance | Inborn genetic diseases | 2022-07-06 | criteria provided, single submitter | clinical testing | The c.190A>G (p.T64A) alteration is located in exon 4 (coding exon 3) of the ANXA11 gene. This alteration results from a A to G substitution at nucleotide position 190, causing the threonine (T) at amino acid position 64 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003427587 | SCV004118595 | uncertain significance | ANXA11-related disorder | 2023-09-18 | criteria provided, single submitter | clinical testing | The ANXA11 c.190A>G variant is predicted to result in the amino acid substitution p.Thr64Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0099% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-81929096-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Labcorp Genetics |
RCV003546863 | SCV004271045 | uncertain significance | not provided | 2023-07-25 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 64 of the ANXA11 protein (p.Thr64Ala). This variant is present in population databases (rs775879177, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ANXA11-related conditions. ClinVar contains an entry for this variant (Variation ID: 2208441). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |